Chinese (SSE) Drug Retail Industry Analysis

Industry Valuation and Performance

Has the Chinese Drug Retail Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sun, 16 Aug 2026	CN¥87.4b	CN¥122.8b	CN¥4.2b	25.4x	20.8x	0.7x
Tue, 14 Jul 2026	CN¥77.5b	CN¥122.8b	CN¥4.2b	21.7x	18.4x	0.6x
Thu, 11 Jun 2026	CN¥78.4b	CN¥122.8b	CN¥4.2b	22.7x	18.7x	0.6x
Sat, 09 May 2026	CN¥87.8b	CN¥123.2b	CN¥4.2b	26.3x	21x	0.7x
Mon, 06 Apr 2026	CN¥88.4b	CN¥121.2b	CN¥3.6b	24.6x	24.6x	0.7x
Wed, 04 Mar 2026	CN¥91.8b	CN¥121.2b	CN¥3.6b	26.3x	25.5x	0.8x
Fri, 30 Jan 2026	CN¥97.6b	CN¥121.2b	CN¥3.6b	28.9x	27.1x	0.8x
Sun, 28 Dec 2025	CN¥91.9b	CN¥121.2b	CN¥3.6b	27.8x	25.5x	0.8x
Tue, 25 Nov 2025	CN¥86.8b	CN¥121.2b	CN¥3.6b	28.8x	24.1x	0.7x
Thu, 23 Oct 2025	CN¥91.4b	CN¥120.6b	CN¥3.3b	30.8x	27.4x	0.8x
Sat, 20 Sep 2025	CN¥90.3b	CN¥120.6b	CN¥3.3b	30.9x	27.1x	0.7x
Mon, 18 Aug 2025	CN¥90.3b	CN¥120.5b	CN¥3.2b	30.4x	27.9x	0.8x
Wed, 16 Jul 2025	CN¥90.7b	CN¥120.4b	CN¥3.3b	30.9x	27.8x	0.8x
Fri, 13 Jun 2025	CN¥96.1b	CN¥120.4b	CN¥3.3b	32.4x	29.5x	0.8x
Sun, 11 May 2025	CN¥95.3b	CN¥120.4b	CN¥3.3b	30.5x	29.2x	0.8x
Tue, 08 Apr 2025	CN¥84.7b	CN¥121.0b	CN¥3.9b	20.8x	21.7x	0.7x
Thu, 06 Mar 2025	CN¥82.4b	CN¥121.0b	CN¥3.9b	18.9x	21.1x	0.7x
Sat, 01 Feb 2025	CN¥80.6b	CN¥121.0b	CN¥3.9b	18.6x	20.7x	0.7x
Mon, 30 Dec 2024	CN¥88.3b	CN¥121.0b	CN¥3.9b	20.4x	22.6x	0.7x
Wed, 27 Nov 2024	CN¥86.5b	CN¥121.0b	CN¥3.9b	19.3x	22.2x	0.7x
Fri, 25 Oct 2024	CN¥84.5b	CN¥119.6b	CN¥4.3b	19.5x	19.5x	0.7x
Sun, 22 Sep 2024	CN¥69.2b	CN¥119.6b	CN¥4.3b	15.7x	16x	0.6x
Tue, 20 Aug 2024	CN¥71.1b	CN¥118.4b	CN¥4.8b	15.9x	14.8x	0.6x
Thu, 18 Jul 2024	CN¥78.2b	CN¥118.4b	CN¥4.8b	18.7x	16.3x	0.7x
Sat, 15 Jun 2024	CN¥101.0b	CN¥118.4b	CN¥4.8b	23.9x	21.1x	0.9x
Mon, 13 May 2024	CN¥127.0b	CN¥118.4b	CN¥4.8b	26.7x	26.5x	1.1x
Wed, 10 Apr 2024	CN¥118.3b	CN¥114.8b	CN¥5.2b	21.8x	22.6x	1x
Fri, 08 Mar 2024	CN¥111.6b	CN¥115.9b	CN¥5.8b	19.2x	19.2x	1x
Sun, 04 Feb 2024	CN¥111.5b	CN¥116.0b	CN¥5.7b	19.6x	19.4x	1x
Tue, 02 Jan 2024	CN¥128.1b	CN¥116.0b	CN¥5.7b	22x	22.3x	1.1x
Thu, 30 Nov 2023	CN¥128.8b	CN¥116.0b	CN¥5.7b	22.7x	22.5x	1.1x
Sat, 28 Oct 2023	CN¥115.4b	CN¥113.6b	CN¥5.7b	22x	20.3x	1x
Mon, 25 Sep 2023	CN¥120.7b	CN¥113.6b	CN¥5.7b	23.4x	21.3x	1.1x
Wed, 23 Aug 2023	CN¥125.9b	CN¥110.0b	CN¥5.5b	27x	23x	1.1x

Current Industry PE

Investors are relatively neutral on the Chinese Drug Retail industry at the moment, indicating that they anticipate long term growth rates to remain steady.

The industry is trading close to its 3-year average PE ratio of 22.8x.

The industry is trading close to its 3-year average PS ratio of 0.81x.

Past Earnings Growth

The earnings for companies in the Drug Retail industry have declined 8.4% per year over the last three years.
Meanwhile revenues for these companies have grown 3.7% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Chinese Drug Retail compare with similar industries?


CN Market	0.19%
Consumer Staples	1.04%
Food and Staples Retail	2.48%
Drug Retail	6.97%
Big Box Super Stores	4.09%
Food Retail	-0.45%
Food Distributors	-2.59%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
603939 Yifeng Pharmacy Chain	CN¥24.03	8.5% +CN¥2.3b	2.8%	PE16.9x
603883 LBX Pharmacy Chain	CN¥13.58	9.6% +CN¥903.1m	-25.4%	PE26.1x
301408 Anhui Huaren Health Pharmaceutical	CN¥17.08	9.9% +CN¥616.0m	15.6%	PE32.6x
603233 DaShenLin Pharmaceutical Group	CN¥17.91	2.3% +CN¥455.5m	5.1%	PE15.9x
300937 Sichuan Hezong Medicine Easy-to-buy Pharmaceutical	CN¥30.70	17.1% +CN¥429.5m	4.1%	PS0.7x

Company

Last Price

Valuation

603939 Yifeng Pharmacy Chain

CN¥24.03

8.5%
+CN¥2.3b

2.8%

PE16.9x

603883 LBX Pharmacy Chain

CN¥13.58

9.6%
+CN¥903.1m

-25.4%

PE26.1x

301408 Anhui Huaren Health Pharmaceutical

CN¥17.08

9.9%
+CN¥616.0m

15.6%

PE32.6x

603233 DaShenLin Pharmaceutical Group

CN¥17.91

2.3%
+CN¥455.5m

5.1%

PE15.9x

300937 Sichuan Hezong Medicine Easy-to-buy Pharmaceutical

CN¥30.70

17.1%
+CN¥429.5m

4.1%

PS0.7x

Anhui Huaren Health Pharmaceutical Co., Ltd. announced that it expects to receive CNY 709.0743 million in funding

Anhui Huaren Health Pharmaceutical Co., Ltd. announced a private placement to issue 50,000,000 A shares at issue price of not less than 80% of the average price in the 20 trading days before the pricing reference date for gross proceeds of CNY 709,074,300 on August 10, 2026. The shares cannot be transferred within 6 months from the issuance closing date. The transaction has been approved approved in the 15TH Meeting of the Company’s 5TH Directorate, and is subject to the approvals of the Company’s Shareholders, the Shenzhen Stock Exchange, and the China Securities Regulatory Commission. The transaction will include participation from not more than 35 investors.

Chinese (SSE) Drug Retail Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

LBX Pharmacy Chain Joint Stock Company (SHSE:603883) announces an Equity Buyback for CNY 80 million worth of its shares.

Anhui Huaren Health Pharmaceutical Co., Ltd. announced that it expects to receive CNY 709.0743 million in funding

Investor sentiment improves as stock rises 23%

Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) announces an Equity Buyback for CNY 300 million worth of its shares.

Investor sentiment improves as stock rises 15%

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. to Report First Half, 2026 Results on Aug 25, 2026

Yixintang Pharmaceutical Group Co., Ltd. to Report First Half, 2026 Results on Aug 27, 2026

ShuYu Civilian Pharmacy Corp., Ltd. to Report First Half, 2026 Results on Aug 26, 2026